pT379-MOP (IHC-grade phospho-µ-Opioid Receptor Antibody)

NEW

KO-Validated

Immunohistochemical Identification of Agonist-induced Threonine379 phosphorylation of the µ-Opioid Receptor in mouse spinal cord

$ 500.00 *

Prices plus VAT plus shipping costs

Ready to ship today,
Delivery time appr. 5-8 days

Order number: 7TM0319E-IC
Content: 300 µl
Host: Rabbit

Threonine379 (T379) is a major phosphorylation site of the µ-opioid receptor (MOP). The... more

Close menu

Threonine379 (T379) is a major phosphorylation site of the µ-opioid receptor (MOP). The pT379-MOP antibody detects phosphorylation in response to high-efficacy agonists but to low-efficacy agonists or after PKC activation. T379 phosphorylation is a key regulator of MOP desensitization, β-arrestin recruitment and tolerance. The pT379-MOP antibody can detect phosphorylated MOP in mouse brain in vivo.

Available downloads:

Alternative Names MOP, OPRM1, µ-Opioid Receptor, Mu Receptor IUPHAR... more

Close menu

Alternative Names	MOP, OPRM1, µ-Opioid Receptor, Mu Receptor
IUPHAR Target ID	319
UniProt ID	P35372 (human) P42866 (mouse) P33535 (rat)
Immunohistochemistry (IHC)	1:50
Species Reactivity	Human, Mouse, Rat
Host / Isotype	Rabbit / IgG
Class	Polyclonal
Immunogen	A synthetic phosphopeptide derived from human MOP around the phosphorylation site of Thr379.
Form	Liquid
Purification	Antigen affinity chromatography
Storage buffer	Dulbecco's PBS, pH 7.4, with 150 mM NaCl, 0.02% sodium azide
Storage conditions	short-term 4°C, long-term -20°C

Figure 1. Immunohistochemical Identification of Agonist-induced Threonine379 phosphorylation of... more

Close menu

Figure 1. Immunohistochemical Identification of Agonist-induced Threonine379 phosphorylation of the µ-Opioid Receptor in mouse spinal cord. Mice were either injected subcutaneously with saline or fentanyl citrate (0,3 mg/kg bodyweight) for 15 min. Animals were then transcardially perfused, fixed and stained in presence of phosphatase and protease inhibitors. Shown are confocal images of coronal sections of the spinal cord stained with the anti-pT379-MOP antibody (7TM0319E-IC).

Fritzwanker S, Nagel F, Kliewer A, Stammer V, Schulz S. In situ visualization of opioid and... more

Close menu

Fritzwanker S, Nagel F, Kliewer A, Stammer V, Schulz S. In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies. Commun Biol. 2023 Apr 15;6(1):419. doi: 10.1038/s42003-023-04786-2. PMID: 37061609; PMCID: PMC10105690.

Close menu